Skip to content

Biohaven BHVN Available-for-Sale Debt Securities - Amortized Cost (<1 Year)

Available-for-Sale Debt Securities - Amortized Cost (<1 Year) at other companies

Dime Community Bancshares
 logo
Dime Community Bancshares DCOM
$13.17M+64.4%
Corebridge Financial logo
Corebridge FinancialCRBG
$3.32B-0.9%
Bank of Hawaii logo
Bank of HawaiiBOH
$106.6M
GBC
Glacier BancorpGBCI
$311.13M-41.9%
1st Source Corporation logo
1st Source CorporationSRCE
$114.57M-58.7%
Wintrust Financial logo
Wintrust FinancialWTFC
$52.66M-14.6%

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.25B-48.1%
Enterprise value$2.26B-46.3%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's available-for-sale debt securities - amortized cost (<1 year).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biohaven's available-for-sale debt securities - amortized cost (<1 year)?
Biohaven (BHVN) reported available-for-sale debt securities - amortized cost (<1 year) of $150.53M in Q1 2026.
How has Biohaven's available-for-sale debt securities - amortized cost (<1 year) changed year-over-year?
Biohaven's available-for-sale debt securities - amortized cost (<1 year) decreased by 32.9% year-over-year, from $224.29M to $150.53M.
What is the long-term trend for Biohaven's available-for-sale debt securities - amortized cost (<1 year)?
Over 3 years (2022 to 2025), Biohaven's available-for-sale debt securities - amortized cost (<1 year) has grown at a -28.4% compound annual growth rate (CAGR), from $310.51M to $114.11M.